Growing community of inventors

Hilleroed, Denmark

Simon Bjerregaard Jensen

Average Co-Inventor Count = 3.48

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 27

Simon Bjerregaard JensenPer Sauerberg (2 patents)Simon Bjerregaard JensenFlemming Seier Nielsen (2 patents)Simon Bjerregaard JensenBetty L Pedersen (2 patents)Simon Bjerregaard JensenErik Skibsted (2 patents)Simon Bjerregaard JensenSvend Havelund (1 patent)Simon Bjerregaard JensenDorthe Kot Engelund (1 patent)Simon Bjerregaard JensenJames M Flink (1 patent)Simon Bjerregaard JensenSilke Møller Larsen (1 patent)Simon Bjerregaard JensenSimon Bjerregaard Jensen (4 patents)Per SauerbergPer Sauerberg (98 patents)Flemming Seier NielsenFlemming Seier Nielsen (11 patents)Betty L PedersenBetty L Pedersen (4 patents)Erik SkibstedErik Skibsted (2 patents)Svend HavelundSvend Havelund (33 patents)Dorthe Kot EngelundDorthe Kot Engelund (8 patents)James M FlinkJames M Flink (7 patents)Silke Møller LarsenSilke Møller Larsen (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novo Nordisk A/s (4 from 1,777 patents)


4 patents:

1. 11033499 - Tablet formulation comprising a GLP-1 peptide and a delivery agent

2. 9993430 - Tablet formulation comprising semaglutide and a delivery agent

3. 9387176 - Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein

4. 8846618 - Stable formulation of modified GLP-1

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…